Literature DB >> 6277121

Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus.

G A Cerasola, M Donatelli, D Sinagra, V Russo, L M Amico, G Lodato.   

Abstract

Fifteen juvenile diabetic patients with normal eye fundus, 6 with non proliferative retinopathy, 5 with proliferative retinopathy and 5 healthy control subjects were studied in order to investigate pituitary function in relation to diabetic retinopathy. ACTH values at 08(00) and 18(00), hPRL and TSh secretion in response to 200 microgram TRH i.v., and GH secretion in response to 500 mg oral L-dopa were evaluated. In all diabetic subjects, 08(00) ACTH levels were lower than in controls. Basal hPRL, TSH and GH values of the diabetics did not differ from those of the controls. No significant differences were found in hPRL levels in response to TRH, whereas significantly lower TSH responses were found in the diabetics. L-dopa caused a significantly different response of GH in the diabetic subjects compared to controls. There is thus a considerable derangement in pituitary hormone secretion in juvenile diabetics mellitus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6277121     DOI: 10.1007/bf02042815

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  13 in total

Review 1.  [Diabetic angiopathy].

Authors:  K Lundbaek
Journal:  Acta Diabetol Lat       Date:  1973 Mar-Apr

2.  Influence of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy.

Authors:  P Passa; C Gauville; J Canivet
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

3.  Growth hormone response to L-dopa in diabetes mellitus.

Authors:  V Sekhuja; G K Rastogi; R Sialy
Journal:  Acta Diabetol Lat       Date:  1976 Sep-Dec

4.  Diabetic retinopathy and prolactin.

Authors:  A Froland; C Hagen; E Lauritzen
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

Review 5.  The pathogenesis of diabetic angiopathy and growth hormone.

Authors:  K Lundbaek; N J Christensen; V A Jensen; K Johansen; T S Olsen; A P Hansen; H Orskov; R Osterby
Journal:  Dan Med Bull       Date:  1971-02

6.  Variation of blood glucose and serum growth hormone, prolactin and insulin in subjects with insulin-dependent diabetes, after OGTT and pretreatment with 2-Br-alpha-ergocryptine.

Authors:  A Gnudi; R Lugari; M G Cavazzini
Journal:  Acta Diabetol Lat       Date:  1977 May-Aug

7.  Human growth hormone secretion after double stimulation with arginine in normal and insulin-dependent diabetic women.

Authors:  L Koncz; S Soeldner; M C Balodimos; G Boden; R E Gleason; D Younger
Journal:  Diabetes       Date:  1973-09       Impact factor: 9.461

8.  Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin.

Authors:  K F Hanssen; S E Christensen; A P Hansen; K Lundbaek; P A Torjesen; J Weeke
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

9.  Growth hormone's role in diabetic microangiopathy.

Authors:  K Lundbaek
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

10.  Dopaminergic stimulation of HGH in diabetes mellitus and in obesity.

Authors:  G Gragnoli; V Palazzuoli; R Favilli; I Tanganelli; G Migliarese
Journal:  Acta Diabetol Lat       Date:  1977 May-Aug
View more
  4 in total

Review 1.  Diabetic retinopathy and pregnancy.

Authors:  Nicola Pescosolido; Orazio Campagna; Andrea Barbato
Journal:  Int Ophthalmol       Date:  2014-01-31       Impact factor: 2.031

2.  The GABAergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate.

Authors:  V Coiro; C Davoli; R Volpi; E Sorini; E Voltini; G Rossi; R Delsignore; A Gnudi; P Chiodera
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

3.  High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins.

Authors:  Edith Arnold; José C Rivera; Stéphanie Thebault; Daniel Moreno-Páramo; Hugo Quiroz-Mercado; Andrés Quintanar-Stéphano; Nadine Binart; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

Review 4.  Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.

Authors:  Jakob Triebel; Thomas Bertsch; Carmen Clapp
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.